glp-1 drug boom Eli Lilly, Novo Nordisk expand operations amid it’s the perfect companion for anyone using GLP Is the GLP-1 compounding boom

EX, Exenatide EX-LAR, Long-acting release formulation of exenatide

The approval status and availability of this class of drugs vary widely across the globe

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

J Appl Physiol (1985) (2017) 123(1):718

They are intended for general informational purposes only and do not constitute a medical guarantee or promise of outcome

Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells